Status:

WITHDRAWN

Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression

Lead Sponsor:

VA Office of Research and Development

Conditions:

Schizophrenia

Depressive Disorder, Major

Eligibility:

All Genders

18-65 years

Brief Summary

The investigators will acquire simultaneous EEG and fMRI data from Veterans with depression and schizophrenia and mentally healthy Veterans to assess early sensory responses, context updating, and res...

Detailed Description

Is "the idle mind the devil's playground?" It depends on where the wandering mind goes. If it is busy reflecting on recent activity, consolidating recent material into long term memories, and envision...

Eligibility Criteria

Inclusion

  • (All)
  • Veterans
  • 18-65 years of age
  • Negative metal screen for MR scanning
  • Corrected to normal vision
  • Inclusion Criteria (patients):
  • Meet criteria for SZ or MDD as assessed using the Structured Clinical Interview for DSM (SCID), with a consensus diagnosis between trained research staff member and an attending psychiatrist or psychologist.
  • Stable medication regime for \> 1 month

Exclusion

  • (All)
  • Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive sequelae)
  • Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic sequelae
  • Major medical conditions (e.g., significant hypertension, diabetes not controlled by diet alone, seizure disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology)
  • Substance abuse within three months of participation or any history of substance dependence
  • History of HIV risk behaviors
  • Known claustrophobia
  • Pregnancy. If the participant cannot rule out pregnancy, a pregnancy urine test will be conducted moments before scanning.
  • Uncorrected vision as assessed by the Snellen chart.
  • Exclusion criteria (patients only):
  • \- Any primary Diagnostic and Statistical Manual Diploma in Social Medicine (DSM) Axis I diagnosis other than SZ or MDD
  • Exclusion criteria (controls only):
  • Any past or present DSM Axis I diagnosis
  • Chronic treatment with medication that affects cognitive function

Key Trial Info

Start Date :

November 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 2 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03758495

Start Date

November 1 2018

End Date

November 2 2018

Last Update

January 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

San Francisco VA Medical Center, San Francisco, CA

San Francisco, California, United States, 94121